Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...
Illumina, Commercial Metals and Newmont stand out as brokers boost ratings amid inflation concerns and shifting economic signals.
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
As a prominent force in DNA sequencing and array-based technologies, Illumina has been deeply committed to China for two decades. Despite market challenges, Illumina remains steadfast in its mission ...
Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...
Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and susceptibility to diseases like Type 2 diabetes, in a study co-led by ...
In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.
The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...
The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.
Oxford Nanopore Technologies plc ( OTCPK:ONTTF) Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:45 AM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback